Dutch Migraine Genetic Research Group (DMGRG)
2001 2000 1999 Key publications before 1999
 

2001:

Lesnik Oberstein SA, van den Boom R, van Buchem MA, van Houwelingen HC, Bakker E, Vollebregt E, Ferrari MD, Breuning MH, Haan J.
Cerebral microbleeds in CADASIL.
Neurology. 2001 Sep 25;57(6):1066-70.

Ophoff RA, DeYoung J, Service SK, Joosse M, Caffo NA, Sandkuijl LA, Terwindt GM, Haan J, van den Maagdenberg AM, Jen J, Baloh RW, Barilla-LaBarca ML, Saccone NL, Atkinson JP, Ferrari MD, Freimer NB, Frants RR.
Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3.
Am J Hum Genet. 2001 Aug;69(2):447-53.

Diener HC, Tfelt-Hansen P, de Beukelaar F, Ferrari MD, Olesen J, Dahlof C, Mathew N.
The efficacy and safety of sc Alniditan vs. sc Sumatriptan in the acute treatment of migraina randomized, double-blind, placebo-controlled trial.
Cephalalgia. 2001 Jul;21(6):672-9.

Kors EE, Terwindt GM, Vermeulen FL, Fitzsimons RB, Jardine PE, Heywood P, Love S, van den Maagdenberg AM, Haan J, Frants RR, Ferrari MD.
Delayed cerebral edema and fatal coma after minor head traumrole of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine.
Ann Neurol. 2001 Jun;49(6):753-60.

Terwindt GM, Ophoff RA, van Eijk R, Vergouwe MN, Haan J, Frants RR, Sandkuijl LA, Ferrari MD.
Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura.
Neurology. 2001 Apr 24;56(8):1028-32.

Ferrari MD, Loder E, McCarroll KA, Lines CR.
Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials.
Cephalalgia. 2001 Mar;21(2):129-36.

Oberstein SA, Bakker E, Ferrari MD, Haan J.
[From gene to disease; from Notch3 to cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy]. Ned Tijdschr Geneeskd. 2001 Feb 24;145(8):359-60. Review. Dutch.

Kors EE, Haan J, Frants RR, Ferrari MD.
[From gene to disease; from CACNA1A to migraine].
Ned Tijdschr Geneeskd. 2001 Feb 10;145(6):266-7. Review. Dutch.

Ophoff RA, van den Maagdenberg AM, Roon KI, Ferrari MD, Frants RR.
The impact of pharmacogenetics for migraine.
Eur J Pharmacol. 2001 Feb 9;413(1):1-10. Review.

 

2000:

Haan J, Sluis P, Sluis LH, Ferrari MD.
Acetazolamide treatment for migraine aura status.
Neurology. 2000 Nov 28;55(10):1588-9. No abstract available.

Dahlof CG, Lipton RB, McCarroll KA, Kramer MS, Lines CR, Ferrari MD.
Within-patient consistency of response of rizatriptan for treating migraine.
Neurology. 2000 Nov 28;55(10):1511-6.

Tfelt-Hansen P, Block G, Dahlof C, Diener HC, Ferrari MD, Goadsby PJ, Guidetti V, Jones B, Lipton RB, Massiou H, Meinert C, Sandrini G, Steiner T, Winter PB.
Guidelines for controlled trials of drugs in migrainsecond edition.
Cephalalgia. 2000 Nov;20(9):765-86. No abstract available.

Haan J, Kors EE, Terwindt GM, Vermeulen FL, Vergouwe MN, van den Maagdenberg AM, Gill DS, Pascual J, Ophoff RA, Frants RR, Ferrari.
Alternating hemiplegia of childhood: no mutations in the familial hemiplegic migraine CACNA1A gene.
Cephalalgia. 2000 Oct;20(8):696-700.

Ferrari MD, Haan J.
Migraine aura, illusory vertical splitting, and Picasso.
Cephalalgia. 2000 Oct;20(8):686. No abstract available.

Ferrari MD.
Rizatriptan a new milestone in migraine treatment. Introduction.
Cephalalgia. 2000;20 Suppl 1:1. No abstract available.

Terwindt GM, Ferrari MD, Tijhuis M, Groenen SM, Picavet HS, Launer LJ.
The impact of migraine on quality of life in the general population: the GEM study.
Neurology. 2000 Sep 12;55(5):624-9.

Spierings EL, Al-Shekhlee A, Reed R, Goadsby PJ, Ferrari MD, Stovner LJ, Senard JM, Jackson NC, Poole PH.
Eletriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan
Neurology. 2000 Sep 12;55(5):735-42. No abstract available.

Roon KI, Bakker D, van Poelgeest MI, van Buchem MA, Ferrari MD, Middelkoop HA.
The influence of ergotamine abuse on psychological and cognitive functioning.
Cephalalgia. 2000 Jun;20(5):462-9.

Haan J, Ferrari MD.
Mahler's migraine.
Cephalalgia. 2000 May;20(4):254. No abstract available.

Plomp JJ, Vergouwe MN, Van den Maagdenberg AM, Ferrari MD, Frants RR, Molenaar PC.
Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha(1A) Ca(2+) channel mutation.
Brain. 2000 Mar;123 Pt 3:463-71.

Roon KI, Olesen J, Diener HC, Ellis P, Hettiarachchi J, Poole PH, Christianssen I, Kleinermans  D, Kok JG, Ferrari MD.
No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: results of two randomized, double-blind, placebo-controlled clinical trials.
Ann Neurol. 2000 Feb;47(2):238-41.

Tfelt-Hansen P, Saxena PR, Dahlof C, Pascual J, Lainez M, Henry P, Diener H, Schoenen J, Ferrari MD, Goadsby PJ. 
Ergotamine in the acute treatment of migraine: a review and European consensus.
Brain. 2000 Jan;123 ( Pt 1):9-18. Review

Goadsby PJ, Ferrari MD, Olesen J, Stovner LJ, Senard JM, Jackson NC, Poole PH. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Neurology. 2000 Jan 11;54(1):156-63.

 

1999:

 

Roon KI, Sandor PS, Schoonman GG, Lamers FP, Schoenen J, Ferrari MD, van Dijk JG.
Auditory evoked potentials in the assessment of central nervous system effects of antimigraine drugs.
Cephalalgia. 1999 Dec;19(10):880-5.

Sandor PS, Roon KI, Ferrari MD, van Dijk JG, Schoenen J.
Repeatability of the intensity dependence of cortical auditory evoked potentials in the assessment of cortical information processing.
Cephalalgia. 1999 Dec;19(10):873-9.

Roon KI, Sandor PS, Schoonman GG, Lamers FP, Schoenen J, Ferrari MD, van Dijk JG.
Auditory evoked potentials in the assessment of central nervous system effects
of antimigraine drugs.
Cephalalgia. 1999 Dec;19(10):880-5.

Sandor PS, Roon KI, Ferrari MD, van Dijk JG, Schoenen J.
Repeatability of the intensity dependence of cortical auditory evoked potentials in the assessment of cortical information processing.
Cephalalgia. 1999 Dec;19(10):873-9.

Roon KI, Maassen Van Den Brink A, Ferrari MD, Saxena PR.
Bovine isolated middle cerebral artery contractions to antimigraine drugs. 
Naunyn Schmiedebergs Arch Pharmacol. 1999 Nov;360(5):591-6.

Lammers GJ, van Dijk JG, Ferrari MD, van Gerven JM, Declerck AC, Troost J.
[Gammahydroxybutyrate must remain available for patients with narcolepsy].
Ned Tijdschr Geneeskd. 1999 Oct 9;143(41):2062-3. Dutch.

Maassen VanDenBrink A, Bax WA, Ramrattan NN, Ferrari MD, Saxena PR.
Human isolated coronary artery contraction to sumatriptan: a post hoc analysis.
Cephalalgia. 1999 Sep;19(7):651-4.

Launer LJ, Terwindt GM, Ferrari MD.
The prevalence and characteristics of migraine in a population-based cohort: the GEM study.
Neurology. 1999 Aug 11;53(3):537-42.

Frants RR. 
The use of isolates in migraine genetic research.
Cephalalgia. 1999 Jul;19 Suppl 24:19-21; discussion 21-4. Review.

Kors EE, Haan J, Ferrari MD.
Genetics of primary headaches.
Curr Opin Neurol. 1999 Jun;12(3):249-54. Review.

Oberstein SA, Ferrari MD, Bakker E, van Gestel J, Kneppers AL, Frants RR, Breuning MH, Haan J.
Diagnostic Notch3 sequence analysis in CADASIL: three new mutations in Dutch
patients. Dutch CADASIL Research Group.
Neurology. 1999 Jun 10;52(9):1913-5.

Roon KI, Soons PA, Uitendaal MP, de Beukelaar F, Ferrari MD.
Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacks.
Br J Clin Pharmacol. 1999 Mar;47(3):285-90.

Haan J, Terwindt GM, Maassen JA, 't Hart LM, Frants RR, Ferrari MD.
Search for mitochondrial DNA mutations in migraine subgroups.
Cephalalgia. 1999 Jan;19(1):20-2.

van Dijk JG, Ferrari MD.
Nerve conduction sensitivity in diabetic neuropathy.
Muscle Nerve. 1999 Jan;22(1):140-1. 

 

Key publications before 1999:

Terwindt GM, Ophoff RA, Haan J, Sandkuijl LA, Frants RR, Ferrari MD. 
Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies. Dutch Migraine Genetics Research Group.
Eur J Hum Genet. 1998 Jul-Aug;6(4):297-307. Review.

Ophoff RA, Terwindt GM, Ferrari MD, Frants RR. 
Genetics and pathology of voltage-gated Ca2+ channels.
Histol Histopathol. 1998 Jul;13(3):827-36. Review.

Maassen VanDenBrink A, Vergouwe MN, Ophoff RA, Naylor SL, Dauwerse HG, Saxena PR, Ferrari MD, Frants RR.
Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients.
Am J Med Genet. 1998 Jun 5;77(5):415-20.

Ophoff RA, Terwindt GM, Frants RR, Ferrari MD. 
P/Q-type Ca2+ channel defects in migraine, ataxia and epilepsy.
Trends Pharmacol Sci. 1998 Apr;19(4):121-7. Review. 

Terwindt GM, Ophoff RA, Haan J, Vergouwe MN, van Eijk R, Frants RR, Ferrari MD. 
Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group.
Neurology. 1998 Apr;50(4):1105-10.

Ferrari MD. 
Migraine.
Lancet. 1998 Apr 4;351(9108):1043-51. Review.

Terwindt GM, Haan J, Ophoff RA, Groenen SM, Storimans CW, Lanser JB, Roos RA, Bleeker-Wagemakers EM, Frants RR, Ferrari MD.
Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. Brain. 1998 Feb;121 ( Pt 2):303-16.

Ophoff RA, Terwindt GM, Vergouwe MN, Frants RR, Ferrari MD.
Familial hemiplegic migraine: involvement of a calcium neuronal channel.
Neurologia. 1997 Dec;12 Suppl 5:31-7. Review

Ophoff RA, Terwindt GM, Vergouwe MN, Frants RR, Ferrari MD. 
Related Articles 

Wolff Award 1997. Involvement of a Ca2+ channel gene in familial hemiplegic migraine and migraine with and without aura. Dutch Migraine Genetics
Research Group.
Headache. 1997 Sep;37(8):479-85. Review.

Terwindt GM, Ophoff RA, Lindhout D, Haan J, Halley DJ, Sandkuijl LA, Brouwer OF, Frants RR, Ferrari MD.
Partial cosegregation of familial hemiplegic migraine and a benign familial infantile epileptic syndrome.
Epilepsia. 1997 Aug;38(8):915-21.

Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR. 
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.
Cell. 1996 Nov 1;87(3):543-52.

Terwindt GM, Ophoff RA, Haan J, Frants RR, Ferrari MD.
Familial hemiplegic migraine: a clinical comparison of families linked and unlinked to chromosome 19.DMG RG.
Cephalalgia. 1996 May;16(3):153-5

Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Mohrenweiser H, Litt M, Hofker MH, Haan J, Ferrari MD, Frants RR.
A 3-Mb region for the familial hemiplegic migraine locus on 19p13.1-p13.2: exclusion of PRKCSH as a candidate gene. Dutch Migraine Genetic Research Group.
Eur J Hum Genet. 1996;4(6):321-8.

Haan J, Terwindt GM, Ophoff RA, Bos PL, Frants RR, Ferrari MD, Krommenhoek T, Lindhout DL, Sandkuyl LA, Van Eyk R.
Is familial hemiplegic migraine a hereditary form of basilar migraine?
Cephalalgia. 1995 Dec;15(6):477-81

Haan J, Terwindt GM, Bos PL, Ophoff RA, Frants RR, Ferrari MD.
Familial hemiplegic migraine in The Netherlands. Dutch Migraine Genetics Research Group.
Clin Neurol Neurosurg. 1994 Aug;96(3):244-9.

Ophoff RA, van Eijk R, Sandkuijl LA, Terwindt GM, Grubben CP, Haan J, Lindhout D, Ferrari MD, Frants RR.
Genetic heterogeneity of familial hemiplegic migraine.
Genomics. 1994 Jul 1;22(1):21-6.